Article bodies are English and are not machine-translated. A name in another language is not a translation of the article.
Fletikumab (NNC0109-0012) (INN ) is a monoclonal antibody designed for the treatment of rheumatoid arthritis that targets IL-20. This drug was being developed by Novo Nordisk A/S until Novo ceased work in inflammation.